Finch Therapeutics Group
(OTC) FNCH
Finch Therapeutics Group Financials at a Glance
Market Cap
$19.27M
Revenue (TTM)
$2.85M
Net Income (TTM)
$14.17M
EPS (TTM)
$0.00
P/E Ratio
-1.36
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$12.00
Volume
2,002
Open
$12.03
Price
$12.00
Volume
2,002
Open
$12.03
Previous Close
$12.00
Daily Range
$12.00 - $12.03
52-Week Range
$11.50 - $16.10
Dividend
$0.00
Beta (Volatility)
0.66 (Low)
Price
$12.00
Volume
2,002
Open
$12.03
Previous Close
$12.00
Daily Range
$12.00 - $12.03
52-Week Range
$11.50 - $16.10
FNCH News
FNCH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Finch Therapeutics Group
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Matthew P. Blischak
Website
www.finchtherapeutics.comHeadquarters
Somerville, MA 02143, US
FNCH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-40%
Return on Assets
-28%
Earnings Yield
-73.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$19.27M
Shares Outstanding
1.61M
Volume
2.00K
Short Interest
0.00%
Avg. Volume
1.15K
Financials (TTM)
Gross Profit
$174.00K
Operating Income
$18.86M
EBITDA
$13.70M
Operating Cash Flow
$31.50M
Capital Expenditure
$0.00
Free Cash Flow
$31.50M
Cash & ST Invst.
$10.26M
Total Debt
$27.79M
Finch Therapeutics Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$44.00K
+22.8%
Gross Margin
0.00%
N/A
Market Cap
$19.27M
N/A
Market Cap/Employee
$19.27M
N/A
Employees
1
N/A
Net Income
$4.83M
+30.4%
EBITDA
$6.07M
+32.8%
Quarterly Fundamentals
Net Cash
$12.95M
-530.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$26.89M
-54.2%
Short Term Debt
$4.19M
+26.4%
Return on Assets
-27.89%
N/A
Return on Invested Capital
-40.49%
N/A
Free Cash Flow
$4.73M
+48.4%
Operating Cash Flow
$4.73M
+48.4%